Breaking News

Accord Healthcare implements next generation of Ci-DMS

The project has already reaped many benefits including greater accuracy and efficiency when dispensing material ...

BASF invests in carbon recycling company LanzaTech

The patented biotechnological procedure cuts carbon dioxide emissions by turning carbon monoxide and hydrogen into ...

What does “flexible production” mean in the context of pharmaceutical product filling?

Bausch+Ströbel answers this question by presenting the VarioSys modular production system

Miniaturised organ equivalents for drug testing

Dr Reyk Horland, VP Business Development of TissUse, speaks to Angharad Baldwin of Manufacturing Chemist about a ...

New survey reveals pioneering medical treatments should be available on NHS

New and potentially life-saving medical treatments, such as proton beam therapy, bone marrow transplant and stem cell ...

Bayer Consumer Care licenses inmation software

The Consumer Health company, has signed a global non-expiring licensing agreement to use enterprise:inmation software

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge ...

Ascletis gains approval of innovative drug in China

WuXi STA's partner Ascletis has received approval from National Drug Administration of China for its new drug, Ganovo, ...

Commercial supply of Zilretta supported by Alcami

Alcami's has expanded deployment of its extended workbench laboratory services programme to support the ongoing ...

The role of DoE in early phase development

Classically, the use of Design of Experiments (DoE) has been heavily leveraged in the pharmaceutical industry in late ...

Six months and counting

With 6 months to go until the DSCSA serialisation enforcement deadline kicks in, Manufacturing Chemist caught up with ...

Adequately establishing contamination risk in drug products

Recent changes within the United States Pharmacopoeia (USP) and European Pharmacopoeia (EP) put emphasis on risk ...

Constellium expands R&D capabilities at Brunel University

The aim of the facility is to transition technology from the laboratory to its production facilities around the world

Recipharm acquires Sanofi CMO business in the UK

Sweden's Recipharm has bought Sanofi's contract inhalation drug business plant in the UK